PhenoVista Biosciences Acquired by InSphero | Healthcare M&A Deal

InSphero has completed the acquisition of PhenoVista Biosciences, a diagnostics imaging business in California, for an undisclosed amount. InSphero acquires PhenoVista Biosciences to expand high-content imaging and phenotypic assay capabilities used in drug discovery and safety testing. PhenoVista Biosciences provides advanced imaging and analytics services that complement InSphero’s 3D in vitro models and microphysiological systems for predictive biology and NAMs. The InSphero acquisitions are structured as an add on acquisition and represent strategic healthcare M&A focused on strengthening the US footprint, including CA acquisitions. The strategic acquisition is announced and positioned to broaden access for pharmaceutical and biotechnology customers to industry-ready diagnostics imaging technologies.